Comparison of high-resolution echo-planar spectroscopic imaging with conventional MR imaging of prostate tumors in mice

NMR in Biomedicine

Volumn 18, Issue 5, 2005, Pages 285-292

  Du, Weiling ^a   Fan, Xiaobing ^a   Foxley, Sean ^a   Zamora, Marta ^a   River, Jonathan N ^a   Culp, Rita M ^a   Karczmar, Gregory S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Echo planar spectroscopic imaging; Mouse; MRI; Prostate cancer; Spectral spatial imaging; Tumor

Indexed keywords

BIOMEDICAL ENGINEERING; IMAGE ANALYSIS; IMAGE QUALITY; MAGNETIC RESONANCE IMAGING; ONCOLOGY; SPECTROSCOPIC ANALYSIS; SPECTRUM ANALYSIS;

ECHO-PLANAR SPECTROSCOPIC IMAGING; MOUSE; PROSTATE CANCERS; PROSTATE TUMORS; SPATIAL IMAGING; SPECTRAL IMAGING;

TUMORS;

ARTICLE; CANCER GRAFT; CONTRAST; CONTROLLED STUDY; DEVICE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECHO PLANAR IMAGING; FOURIER TRANSFORMATION; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; RODENT; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; TUMOR MODEL;

ANIMALS; ECHO-PLANAR IMAGING; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; RODENTIA;

EID: 23844506225     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.954     Document Type: Article

References (35)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 1999; 80: 827-841.
2. Rifkin MD. MRI of the prostate. Crit. Rev. Diagn. Imag. 1990; 31: 223-262.
3. Schiebler ML, Tomaszewski JE, Bezzi M, Pollack HM, Kressel HY, Cohen EK, Altman HG, Gefter WB, Wein AJ, Axel L. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 1989; 172: 131-137.
4. Carter HB, Brem RF, Tempany CM, Yang A, Epstein JI, Walsh PC, Zerhouni EA. Nonpalpable prostate cancer: detection with MR imaging. Radiology 1991; 178: 523-525.
5. Huch Boni RA, Boner JA, Lutolf UM, Trinkler F, Pestalozzi DM, Krestin GP. Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma. J. Comput. Assist Tomogr. 1995; 19: 232-237.
6. Turnbull LW, Buckley DL, Turnbull LS, Liney GP, Knowles AJ. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J. Magn. Reson. Imag. 1999; 9: 311-316.
7. Swanson MG, Vigneron DB, Tran TK, Sailasuta N, Hurd RE, Kurhanewicz J. Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue. Magn. Reson. Med. 2001; 45: 973-980.
8. Song SK, Qu Z, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJ. Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res. 2002; 62: 1555-1558.
9. 2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn. Reson. Med. 2001; 46: 1054-1058.
10. *) weighting. Magn. Reson. Med. 1999; 41: 423-428.
11. Sarkar S, Heberlein K, Metzger GJ, Zhang X, Hu X. Applications of high-resolution echoplanar spectroscopic imaging for structural imaging. J. Magn. Reson. Imag. 1999; 10: 1-7.
12. Oikawa H, Al-Hallaq HA, Lewis MZ, River JN, Kovar DA, Karczmar GS. Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia. Magn. Reson. Med. 1997; 38: 27-32.
13. Al-Hallaq HA, Zamora M, Fish BL, Farrell A, Moulder JE, Karczmar GS. MRI measurements correctly predict the relative effect of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Int. J. Radiat. Oncol. Biol. Phys. 2000; 47: 481-488.
14. Karczmar GS, Fan X, Al-Hallaq HA, Zamora M, River JN, Rinker-Schaeffer C, Zaucha M, Tarlo K, Kellar K. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn. Reson. Med. 2000; 43: 633-639.
15. Fan X, River JN, Zamora M, Tarlo K, Kellar K, Rinker-Schaeffer C, Karczmar GS. Differentiation of non-metastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn. Reson. Med. 2001; 45: 1046-1055.
16. Kovar DA, Al-Hallaq HA, Zamora MA, River JN, Karczmar GS. Fast spectroscopic imaging of water and fat resonances to improve the quality of MR images. Acad. Radiol. 1998; 5: 269-275.
17. Du W, Du YP, Bick U, Fan X, MacEneaney PM, Zamora MA, Medved M, Karczmar GS. Breast MR Imaging with high spectral and spatial resolutions: preliminary experience. Radiology 2002; 224: 577-585.
18. Medved M, Du W, Zamora M, Fan X, Olopade F, MacEneaney PM, Newstead G, Karczmar GS. The effect of varying spectral resolution on the quality of high spectral and spatial resolution magnetic resonance images of the breast. J. Magn. Reson. Imag. 2003; 18: 442-448.
19. Brown TR, Kincaid B, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA 1982; 79: 3523.
20. 1H MR spectroscopic imaging - initial results. Radiology 2003; 229: 241-247.
21. Mansfield P. Spatial mapping of the chemical shift in NMR. Magn. Reson. Med. 1984; 1: 370-386.
22. 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn. Reson. Med. 1995; 33: 34-40.
23. Kuroda K, Mulkern RV, Oshio K, Panych LP, Nakai T, Moriya T, Okuda S, Hynynen K, Joles FA. Temperature mapping using the water proton chemical shift: self-referenced method with echoplanar spectroscopic imaging. Magn. Reson. Med. 2000; 43: 220-225.
24. Du W, Du YP, Fan X, Zamora MA, Karczmar GS. Reduction of spectral ghost artifacts in high-resolution echo-planar spectroscopic imaging of water and fat resonances. Magn. Reson. Med. 2003; 49: 1113-1120.
25. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn. Reson. Med. 1995; 34: 555-566.
26. Kiselev VG, Posse S. Analytical theory of susceptibility induced NMR signal dephasing in a cerebrovascular network. Phys. Rev. Lett. 1998; 81: 5696-5699.
27. Zhong K, Li X, Shachar-Hill Y, Picart F, Wishnia A, Springer CSJ. Magnetic susceptibility shift selected imaging (MESSI) and localized (1)H(2)O spectroscopy in living plant tissues. NMR Biomed. 2000; 13: 392-397.
28. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994; 32: 749-763.
29. Fan X, Du W, MacEneaney PM, Zamora M, Karczmar GS. Structure of the water resonance in small voxels in rat brain detected with high spectral and spatial resolution MRI. J. Magn. Reson. Imag. 2002; 16: 547-552.
30. Al-Hallaq HA, Fan X, Zamora M, River JN, Moulder JE, Karczmar GS. Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed. 2002; 15: 28-36.
31. Twieg DB, Meyerhoff DJ, Hubesch B, Roth K, Sappey-Marinier D, Boska MD, Gober JR, Schaefer S, Weiner MW. Phosphorus-31 magnetic resonance spectroscopy in humans by spectroscopic imaging: localized spectroscopy and metabolite imaging. Magn. Reson. Med. 1989; 12: 291-305.
32. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn. Reson. Med. 1998; 40: 793-799.
33. Al-Hallaq HA, River JN, Zamora M, Oikawa H, Karczmar GS. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys. 1998; 41: 151-159.
34. Tennant TR, Kim H, Sokoloff M, Rinker-Schaeffer CW. The Dunning model. Prostate 2000; 43: 295-302.
35. Medved M, Newstead GM, Fan X, Du W, Du YP, MacEneaney PM, Culp RM, Kelcz F, Olopade OI, Zamora MA, Karczmar GS. Fourier components of inhomogeneously broadened water resonances in breast: a new source of MRI contrast. Magn. Reson. Med. 2004; 52: 193-196.